iRhythm Holdings (IRTC) Cash & Equivalents (2015 - 2026)
iRhythm Holdings' (IRTC) quarterly Cash & Equivalents came in at $240.1 million in Q1 2026, down 36.01% year-on-year from $375.3 million in Q1 2025, and up 1.75% on a QoQ basis from $236.0 million in Q4 2025.
iRhythm Holdings (IRTC) Cash & Equivalents (2015 - 2026) Analysis & Trends
iRhythm Holdings (IRTC) has 12 years of Cash & Equivalents data on file, last reported at $240.1 million in Q1 2026.
- On a quarterly basis, Cash & Equivalents fell 36.01% year-over-year to $240.1 million in Q1 2026; TTM through Mar 2026 was $240.1 million, a 36.01% decrease from a year earlier, with the FY2025 full-year figure at $236.0 million, down 43.75% from the prior year.
- Cash & Equivalents for Q1 2026 stood at $240.1 million, up from $236.0 million in the prior quarter.
- Over the last five years, Cash & Equivalents for IRTC reached as high as $550.6 million in Q2 2024 and fell as low as $36.2 million in Q4 2023.
- Historically, Cash & Equivalents has averaged $219.4 million across 5 years, with a median of $162.5 million in 2025.
- Across the five-year window, Cash & Equivalents sank 69.0% in 2022 and jumped 1059.97% in 2024, its largest moves.
- Year by year, Cash & Equivalents stood at $78.8 million in 2022, then tumbled by 54.11% to $36.2 million in 2023, then soared by 1059.97% to $419.6 million in 2024, then tumbled by 43.75% to $236.0 million in 2025, then climbed by 1.75% to $240.1 million in 2026.
- Per Business Quant data, the three most recent Cash & Equivalents figures were $240.1 million in Q1 2026, $236.0 million in Q4 2025, and $162.5 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 6.80 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 2.88 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 1.95 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 1.45 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 2.45 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 1.12 Bn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 3.03 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 2.29 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 557.00 Mn |
| 10 | iRhythm Holdings | 3.50 Bn | 2.95 Bn | 141.35 Mn | 240.15 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 240.15 Mn |
| Dec 31, 2025 | 236.01 Mn |
| Sep 30, 2025 | 162.47 Mn |
| Jun 30, 2025 | 214.44 Mn |
| Mar 31, 2025 | 375.28 Mn |
| Dec 31, 2024 | 419.60 Mn |
| Sep 30, 2024 | 519.54 Mn |
| Jun 30, 2024 | 550.55 Mn |
| Mar 31, 2024 | 520.42 Mn |
| Dec 31, 2023 | 36.17 Mn |
| Sep 30, 2023 | 47.48 Mn |
| Jun 30, 2023 | 61.58 Mn |
| Mar 31, 2023 | 52.80 Mn |
| Dec 31, 2022 | 78.83 Mn |
| Sep 30, 2022 | 71.22 Mn |
| Jun 30, 2022 | 101.25 Mn |
| Mar 31, 2022 | 42.59 Mn |
| Dec 31, 2021 | 110.14 Mn |
| Sep 30, 2021 | 132.40 Mn |
| Jun 30, 2021 | 104.62 Mn |